Women’s Health Market (Treatment Type - Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, and Others) and Non-Hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, and Others); Disease Indication - Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer), Hypothyroidism, Post-Menopausal Syndrome, Osteoporosis, Contraceptive, Uterine Fibroid, Urinary Tract Infection, and Others)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030
The global Women’s Health market size was estimated at USD 38.12 billion in 2021 and is expected to surpass around USD 58.25 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.10% during the forecast period 2022 to 2030. Market growth can be attributed to the increase in the women geriatric population and the introduction of new products for women’s health, such as Relugoliz and Orilissa among others. Furthermore, favorable policies initiated by governments to improve women’s health and raise awareness are likely to drive the market over the forecast period. The market exhibited lower than the expected growth during the pandemic.
Access to contraception and gynecological testing declined, raising the rate of unsafe abortions and unwanted pregnancies, especially in developing countries. For instance, according to the BMC, in the low- and middle-income countries, there has been around a 10% decline in the use of long- and short-acting reversible contraceptives, about 10% decline in essential services related to pregnancy care. All these factors led to a decline in market growth amid the pandemic. Women are more susceptible to various diseases, such as osteoporosis, osteoarthritis, endometriosis, and menstrual health disorders.
Around 73% of postmenopausal women experience hot flashes, fatigue, and sleep disturbances, which increase dependence on medications, impairing the quality of life. With aging and the increasing prevalence of obesity, the cases of osteoporosis are anticipated to grow. Some of the major factors leading to hormonal imbalance in women are stress, change in dietary habits, and alcohol consumption, which further cause fertility issues. Polycystic Ovarian Syndrome (PCOS), ovulation problems, and endometriosis are some of the major causes of infertility. According to the WHO, in 2021, globally, around 190 million women of reproductive age were affected by endometriosis.
These factors are anticipated to fuel the market growth. According to the United Nations, the Department of Social and Economic Affairs, approximately 1.1 billion women needed family planning in 2019, out of which, 190 million had unmet contraception needs and about 842 million used modern methods of contraception. Owing to the high unmet need for publicly-funded contraceptive services and products, federal & state governments are actively working toward improving family planning services and improving access to modern contraceptives.
For instance, in 2020, Germany’s total multilateral funding for sexual & reproductive and family planning was around USD 121.85 million, an increase of about 65% from 2019. Furthermore, agencies, such as USAID run reproductive health & family planning programs in more than 30 countries, including South Africa & other African countries, where there is a high unmet need for contraception. However, there are various complications and adverse effects of prolonged use of contraceptives, which lead to an increase in the adoption of traditional contraceptive methods.
Report Scope of the Women’s Health Market
US$ 58.25 Billion by 2030
CAGR of 4.10% from 2022 to 2030
Fastest Growing Market
2022 to 2030
Treatment Type ,Disease Indication and Region,
AbbVie, Inc.; Bayer AG; Merck & Co., Inc.; Pfizer, Inc; Teva Pharmaceutical Industries Ltd.; Agile Therapeutics; Amgen, Inc; Apothecus Pharmaceutical Corp.; Blairex Laboratories, Inc.; Ferring B.V.
Some socio-cultural factors holding women back from being benefitted from various quality health services and attaining good health include the following:
- unequal power relationships shared between women and men in all spheres of life;
- exclusive emphasis on the reproductive role of women
- social norms discouraging paid employment opportunities and less or no education
- actual and potential experience of emotional, sexual, and physical violence
- poverty has been an important obstacle to attain positive health outcomes for both women and men and women. However, poverty tends to bestow women with heavier burden on women. For instance, use of unsafe cooking fuels, malnutrition affects mostly women as opposed to men.
The global women’s health market is likely to be adversely impacted by the ongoing outbreak of coronavirus across the globe. While the health of women, particularly in countries with a poor record in violence against women and health of women, continue to overlook the health-related needs of women, particularly working women who continue to work from home and do household chores at the same time. Several programs promoting health of women in both rural and urban areas have come to standstill. However, once tings return to normal, it is expected that there will renewed activities pertaining to promotion of women’s health, which is likely to bolster growth of the global women’s health market in the years to come.
Some of the leading firms in the global women’s health market comprise Apothecus Pharmaceutical Corporation, Ferring Pharmaceuticals, Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd, Lupin Pharmaceuticals, Inc., and Eli Lilly and Company. These companies are making use of various business strategies such as regional expansion, research and development activities for new products, and merger and acquisitions.
Rising Government Initiatives and Awareness to Shoot Up Demand in the Market
There has been a rise in the population of elderly women, i.e. women who are aged above 60 years, introduction of novel treatments and medicines for women, and augmented adoption of unhealthy lifestyle. These factors play significant role in boosting the global women’s health market over the tenure of assessment. In addition to that, favorable government policies, such as Indira Gandhi Matritva Sahyog Yojana in India to monitor the health of a mother, have been introduced to better the condition of women’s health. Government schemes are also aimed at raising the level of awareness about the health of women. Prevalence of such government schemes are likely to work in favor of the growth of the global women’s health market in the years to come.
Women are more vulnerable to diseases like obesity, depression, menstrual health-related disorders, anemia, osteoarthritis, and osteoporosis. There has been wide prevalence of these conditions amongst women and the incidences are rising with many of these conditions beginning quite early, such as osteoarthritis affecting women as young as 30 years. Rising prevalence of these medical conditions is likely to augur well for the global women’s health market for the period of analysis, from 2017 to 2030.
According to the findings of International Osteoporosis Foundation (IOF), a nongovernmental organization based out of Switzerland, incidences of osteoporosis amongst women is likely to reach a figure of 680 million by 2050. IOF is tasked with the treatment, diagnosis, and prevention of osteoporosis across the globe. Besides, mental illnesses, cardiovascular diseases, and breast cancer is likely to substantially add to the burden of non-communicable diseases amongst women. Most women are likely to undergo menopause after the age of 50, which creates hormonal changes and leave an undesirable impact of the quality of life of women. Many of the menopausal women experience hot flashes. The Society of Obstetricians and Gynecologists of Canada (SOGC), national medical society in Canada, presented an estimation that indicates at around 85.0% of women will suffer from at one of the side effects of menopause, which could be irritability or lack or interrupted sleep, and mood swings.
In addition to that, there have been changes in the dietary habits of women as well. More women have taken up consumption of alcohol and smoking, stress at work and home, frequent eating out and consumption of ready to eat food items have all contributed toward the deterioration of health of women. Change in lifestyle habits have caused hormonal imbalance and fertility issues in women, which is likely to support expansion of the global women’s health market in the enar future. These factors are estimated to promote growth of the global women’s health market in the years to come. Polycystic ovarian syndrome (PCOS), endometriosis, and ovulation problems are some of the major problems affecting the health of women.
Driven by the US, North America to Present Lucrative Growth Opportunities
It is estimated that North America, driven by the US, is likely to remain at the forefront of the growth of the global women’s health market over the tenure of assessment, from 2017 to 2030. Increased prevalence of women’s health therapeutics, thanks to the high investment made by both government and private agencies for drug research. These research and development activities have led to the invention of several advanced and sophisticated treatments for women, which is likely to support growth of the women’s health market in North America. In addition there has an increased focus on cancer care for women, which is likely to drive the market in the region. Presence of leading biotechnology and pharmaceutical firms in the region is another growth factor for the women’s health market in the region.
With the presence of a large untapped market, rise in government initiatives, and increasing awareness about the health of women are likely to offer rapid growth opportunities for the women’s health market in Asia Pacific in the years to come
Some of the prominent players in the Women’s Health Market include:
- AbbVie, Inc.
- Bayer AG
- Merck & Co., Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Agile Therapeutics
- Amgen, Inc.
- Apothecus Pharmaceutical Corp.
- Blairex Laboratories, Inc.
- Ferring B.V.
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Women’s Health market
- Hormonal Treatment
- Estrogen Therapy
- Progestin Therapy
- Combination Therapy
- Thyroid Replacement Therapy
- Parathyroid Hormone Therapy
- Non-Hormonal Treatment
- Targeted Therapy Drugs
- Breast Cancer
- Cervical Cancer
- Ovarian Cancer
- Post-Menopausal Syndrome
- Uterine Fibroid
- Urinary Tract Infection
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Points Covered in Women’s Health Market Study:
- Growth of Women’s Health in 2022
- Market Estimates and Forecasts (2017-2030)
- Brand Share and Market Share Analysis
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Recommendation on Key Winning Strategies
- COVID-19 Impact on Demand for Women’s Health and How to Navigate
- Key Product Innovations and Regulatory Climate
- Women’s Health Consumption Analysis
- Women’s Health Production Analysis
- Women’s Health and Management